Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The international empirics of management.
Scur D, Ohlmacher S, Van Reenen J, Bennedsen M, Bloom N, Choudhary A, Foster L, Groenewegen J, Grover A, Hardeman S, Iacovone L, Kambayashi R, Laible MC, Lemos R, Li H, Linarello A, Maliranta M, Medvedev D, Meng C, Miles Touya J, Mandirola N, Ohlsbom R, Ohyama A, Patnaik M, Pereira-López M, Sadun R, Senga T, Qian F, Zimmermann F. Scur D, et al. Among authors: kambayashi r. Proc Natl Acad Sci U S A. 2024 Nov 5;121(45):e2412205121. doi: 10.1073/pnas.2412205121. Epub 2024 Nov 1. Proc Natl Acad Sci U S A. 2024. PMID: 39485796
Drug-induced long QT syndrome: Concept and non-clinical models for predicting the onset of drug-induced torsade de pointes in patients in compliance with ICH E14/S7B guidance.
Sugiyama A, Goto A, Izumi-Nakaseko H, Takei Y, Takahara A, Kambayashi R. Sugiyama A, et al. Among authors: kambayashi r. J Pharmacol Exp Ther. 2024 Aug 21:JPET-MR-2024-002184. doi: 10.1124/jpet.124.002184. Online ahead of print. J Pharmacol Exp Ther. 2024. PMID: 39168651 Free article.
A novel ryanodine receptor 2 inhibitor, M201-A, enhances natriuresis, renal function and lusi-inotropic actions: Preclinical and phase I study.
Kaneko N, Loughrey CM, Smith G, Matsuda R, Hasunuma T, Mark PB, Toda M, Shinozaki M, Otani N, Kayley S, Da Silva Costa A, Martin TP, Dobi S, Saxena P, Shimamoto K, Ishikawa T, Kambayashi R, Riddell A, Elliott EB, McCarroll CS, Sakai T, Mitsuhisa Y, Hirano S, Kitai T, Kusano K, Inoue Y, Nakamura M, Kikuchi M, Toyoda S, Taguchi I, Fujiwara T, Sugiyama A, Kumagai Y, Iwata K. Kaneko N, et al. Among authors: kambayashi r. Br J Pharmacol. 2024 Sep;181(18):3401-3419. doi: 10.1111/bph.16379. Epub 2024 May 21. Br J Pharmacol. 2024. PMID: 38773354 Clinical Trial.
Analyses of the onset mechanisms of cardio-stimulatory action by aciclovir.
Goto A, Kambayashi R, Chiba K, Shinozaki M, Moritani K, Izumi-Nakaseko H, Takei Y, Hirasawa A, Sugiyama A. Goto A, et al. Among authors: kambayashi r. J Pharmacol Sci. 2024 Apr;154(4):294-300. doi: 10.1016/j.jphs.2024.02.005. Epub 2024 Feb 8. J Pharmacol Sci. 2024. PMID: 38485347 Free article.
59 results